Farmacogenética do tratamento da depressão: busca de marcadores moleculares de boa resposta aos antidepressivos
DOI:
https://doi.org/10.1590/S0101-60832004000100007Keywords:
Antidepressant, pharmacogenetics, polymorphismsAbstract
The present article reviews the studies on genetic determinants for drug response to the treatment of depression. These investigations assess the individual differences in the pharmacokinetic mechanisms - such as the genetic variants of genes coding for drug-metabolizing enzymes - and in the pharmacodynamics, looking at the genetic variants of genes coding for drug targets. The authors conclude that the knowledge about the functional variants of the genes coding for antidepressant metabolizing enzymes such as CYP2D6, or genes coding for antidepressant targets such as the serotonin transporter protein (5-HTT), could assist in individualizing the selection of medication and dosage for depression treatment.Downloads
Download data is not yet available.
Downloads
Published
2004-01-01
Issue
Section
Original Articles
License
Once accepted for publication, the manuscript becomes permanent property of the Archives of Clinical Psychiatry. This copyright transfer subsumes exclusive and unlimited entitlement of the Archives of Clinical Psychiatry to publish and distribute the full contents of articles in whichever publishing medium, including press and electronic media, in Brazil and abroad.
Manuscripts are accepted with the understanding that the Editor and the editorial staff have the right to make revisions aimed at greater conciseness, clarity, and conformity with Journal style, of course without changing its content.
How to Cite
Farmacogenética do tratamento da depressão: busca de marcadores moleculares de boa resposta aos antidepressivos . (2004). Archives of Clinical Psychiatry, 31(1), 40-43. https://doi.org/10.1590/S0101-60832004000100007